微创二尖瓣手术后的风险相关临床结局:来自Mini-Mitral国际注册研究的见解
基于Mini-Mitral国际注册研究2015至2021年6541例微创二尖瓣手术患者,按EuroSCORE II分为低、中、高和极高危组。总体手术死亡率和卒中率分别为1.7%和1.4%,且与患者风险显著相关。所有风险组的观察死亡率均显著低于EuroSCORE II预测值(观察/预期比值<1)。
要点
- 低危组占84.8%(5546例),中危组9.4%(615例),高危组2.9%(191例),极高危组2.9%(189例)。
- 总体手术死亡率为1.7%,卒中率为1.4%,均与患者风险显著相关。
- 所有风险组的观察死亡率均显著低于EuroSCORE II预测值(观察/预期比值<1)。
核心结论
- 微创二尖瓣手术在低、中、高危患者中手术结果优良,但在极高危患者中结果欠满意。
- EuroSCORE II模型高估了院内死亡率。
- 作者认为MMIR研究结果可能有助于外科医生和心脏病专家为二尖瓣疾病患者进行临床决策和治疗分配。
研究设计与样本
- 使用Mini-Mitral国际注册(MMIR)数据库分析2015年至2021年间的微创二尖瓣手术。
- 共纳入6541例患者,按EuroSCORE II分为低危(<4%)、中危(4%至<8%)、高危(8%至<12%)和极高危(≥12%)组。
- 计算各风险组的观察/预期死亡率比值。
主要发现
- 5546例(84.8%)为低危,615例(9.4%)为中危,191例(2.9%)为高危,189例(2.9%)为极高危。
- 总体手术死亡率为1.7%,卒中率为1.4%,均与患者风险显著相关。
- 所有风险组的观察死亡率均显著低于EuroSCORE II预测值(观察/预期比值<1)。
关键数值与推荐
- 低危组:EuroSCORE II <4%。
- 中危组:EuroSCORE II 4%至<8%。
- 高危组:EuroSCORE II 8%至<12%。
- 极高危组:EuroSCORE II ≥12%。
临床怎么用
- 作者认为MMIR研究结果可能有助于外科医生和心脏病专家为二尖瓣疾病患者进行临床决策和治疗分配。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: With the popularization of catheter-based mitral valve procedures, evaluating risk-specific differentiated clinical outcomes after contemporary mitral valve surgery is crucial. In this study, we assessed the operative results of minimally invasive mitral valve operations across different patient risk profiles and evaluated the value of EuroSCORE (ES) II predicted risk of mortality model for risk prediction, in the large cohort of Mini-Mitral International Registry (MMIR). METHODS: The MMIR database was used to analyse mini-mitral operations between 2015 and 2021. Patients were categorized as low (<4%), intermediate (4% to <8%), high (8% to <12%) and extreme risk (≥12%) according to ES II. The observed-to-expected mortality ratio was calculated for each risk group. RESULTS: A total of 6541 patients were included in the analysis. Of those, 5546 (84.8%) were classified as low risk, 615 (9.4%) as intermediate risk, 191 (2.9%) as high risk and 189 (2.9%) as extreme risk. Overall operative mortality and stroke rates were 1.7% and 1.4%, respectively, and were significantly associated with patient's risk. The observed mortality was significantly lower than expected-according to the ES II-in all risk categories (observed-to-expected ratio < 1). CONCLUSIONS: The present study provides an international contemporary benchmark for operative outcomes after minimally invasive mitral surgery. Operative results were excellent in low-, intermediate- and high-risk patients, but were less satisfactory in extreme risk. The ES II model overestimated the in-hospital mortality. We believe that findings from the MMIR may assist surgeons and cardiologists in clinical decision-making and treatment allocation for patients with mitral valve disease.
引用
- Berretta P, Kempfert J, Van Praet F, et al. Risk-related clinical outcomes after minimally invasive mitral valve surgery: insights from the Mini-Mitral International Registry. Eur J Cardiothorac Surg. 2023. PMID: 36892446. doi:10.1093/ejcts/ezad090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。